Facts figures and features conference report / CONFERENCE: CROSS-BORDER ITALY-SLOVENIA BIOMEDICAL...

Progetti finanziati nell’ambito del Programma per la Cooperazione Transfrontaliera Italia-Slovenia 2007-2013, dal Fondo europeo di sviluppo regionale e dai fondi nazionali. Projekti sofinancirani v okviru Programa čezmejnega sodelovanja Slovenija-Italija 2007-2013 iz sredstev Evropskega sklada za regionalni razvoj in nacionalnih sredstev.

1

FACTS FIGURES FEATURES

Sabina Passamon+ University of Trieste

Lead Partner of Trans2Care


2

WHY THIS CONFERENCE?

•  Six projects with 44 different partners have received 8.48 MLN € from the Cross-‐Border Coopera+on Programme Italy-‐ Slovenia 2007-‐2013.

•  For the first +me, researchers have met to share their results and future perspec+ves: –  What are the results of this investment? –  Will new scien+fic knowledge produce any technological innova+on? –  Is there any benefit for our quality of life and health? –  Are these researchers ready to successfully compete in Horizon 2020

calls? Read more in the Conference flyer:

h\p://it.trans2care.eu/UserFiles/file/CBISBR_02_2014_full_programme_CMYK.pdf


3

FACTS

1.   Wish to share what we do in our cross-‐border projects – objec+ves, results, vision

2.   Immediate agreement to meet at this Conference

3.  An open event – other colleagues have been invited to the Conference


4

FIGURES of a\rac+on è n of registra+ons The growing curve of registra+ons:

up to 181 on the day of the Conference


5

The geographical origin of the par+cipants

FIGURES of a\rac+on è not just a local event


6

FIGURES of a\rac+on è traffic on the web 686 visualisa+ons of the Conference announcement


7

FIGURES of a\rac+on è 65 posters evaluated for their Technolgy Readiness Levels

h\p://www.flickr.com/photos/trans2care/sets/72157641645322424/with/12830151975/


8

UniversiIes 48%

Research Centers 19% Hospitals

5%

SMEs 9%

Other 19%

Where do the 181 parIcipants work ?


9

Where do researchers come from?

0" 2" 4" 6" 8" 10" 12" 14"

ELETTRA"LNCIB"AREA"NIB"

INFN"KI"

ZTM"CBM"

Research(centers(

N"

0" 5" 10" 15" 20" 25" 30" 35" 40"

Trieste"

Primorska"

Udine"

SISSA"

Nova"Gorica"

Rijeka"

Ferrara"

Venezia"

Verona"

Universi(es)

N"


10

That’s the new FEATURE of this Conference !

The new language of TRL •  Understood by industries •  Understood by H2020 evaluators •  Understood by venture capitalists •  Understood across disciplines


11

T.R.L. ASSESSMENT

FINAL REPORT

Dott. Adriano SAVOINI - T&B e associa+ Srl Trans2Care Project Manager

TRL Evaluation Team Coordinator Team members:

http://it.trans2care.eu/UserFiles/file/whoswhooftheconference.pdf


12

T.R.L. ASSESSMENT RESULTS

0

5

10

15

20

25

1 2 3 4 5 6 7 8 9 N/A

N.posters

TRL


13

CONCLUSIONS / COMMENTS •  Most technologies need (much) further development to be ready for market (average TRL is 3) •  (Apparently) few links with Industry •  4-5 techs seem very promising for market deployment •  N/A = Not applicable; clinical studies, presentation of the Institute, etc.


14

Can this analysis be independently confirmed?

•  Let’s browse the “Bibliometric analysis of ongoing projects-‐Innova+ve Medicines Ini+a+ve Joint Undertaking – Report 2013”

•  We can see how many collabora+ons involve public research ins+tu+ons and industries.

Read more in h\p://www.imi.europa.eu/sites/default/files/uploads/documents/IMI_BibliometricReport_3.pdf


15

?

GO TO PAGE 57 OF THE IMI REPORT


16

Pioneers needed !

for smart biomedical industrialisa1on

It appears that Italy-‐Slovenia Cross-‐border biomedical researchers are not involved in

collabora+ve research projects and networks of industrial and academic experts supported by

Innova+ve Medicine Ini+a+ve


17

Can the Cross-‐border biomedical research community provide the

pioneers ? for smart biomedical industrialisa1on

Let’s analyse the results of our pre-‐conference survey 62 respondents out of ca. 160 registraIons


18

The occupa+onal profile of par+cipants

Permanent(30%(

Temporary(70%(

What(kind(of(job(contract(do(you(have(?(

YES$35%$

NO$65%$

Does%the%CBC%Programme%Italy2Slovenia%200722013%fund%your%

contract?%

25#$#30#29%#

31#$#36#30%#37#$#43#

11%#

44#$#54#24%#

55#$#70#6%#

How$old$are$you$?$


19

i) Clear ideas (turquoise bars) ii) To be a researcher (blue bars) or an employee (red bars); ii) Not to be an employer (green bars)

Research(Enterprise,(as(employee(Enterprise,(as(employer(Other(No(idea(

0,0(

10,0(

20,0(

30,0(

40,0(

50,0(

60,0(

70,0(

unlikely( poorly(likely(

fairly(likely(

likely( most(likely(

9,5$

22,2$

50,8$30,8$

21,2$ 26,9$19,2$

1,9$

57,1$

4,1$

20,4(26,5(

6,1(

66,7(

7,1(

%$

What$do$you$plan$for$your$next$job$?$

Research(

Enterprise,(as(employee(

Enterprise,(as(employer(

Other(

No(idea(

The vision of the par+cipants:


20

i) First choiche: to work at home (red) ii) Second choice: to work close to home (blue) iii) Third choice: to work abroad

In#the#Italy*Slovenia#Programme#Area#In#your#country#Abroad#

0,0#

10,0#

20,0#

30,0#

40,0#

unlikely# poorly#likely#

fairly#likely#

likely# most#likely#

22,2# 12,7#28,6# 19,1#

17,5#

1,7#10,3#

20,7#

29,3#

37,9#38,9#

18,5#

20,4#

14,8#

7,4#

%#

Where#do#you#plan#to#work#in#the#near#future#?#

In#the#Italy*Slovenia#Programme#Area#

In#your#country#

Abroad#

The vision of the par+cipants:


21

WHAT NEEDS TO BE IMPROVED •  More connecIons involving reasearchers, industries and public bodies

•  Intense training of researchers in the methods and techniques fostering innova+on –  effort to develop new skills –  effort to work across disciplines –  effort to interact with non-‐researchers

•  A stronger dialogue with the policy-‐makers and the Managing Authority (not just financial reports and online consulta+ons!)


22

CONCLUSIONS

•  The aim of this Conference was to assess the capacity of biomedical researchers to develop innova+ons. – Note: analysis focussed on "Readiness", not on "quality" of results, methods or approaches

•  There is a large poten+al to progress from the phase of “technological research” to the phase of “technological developments” (i.e from TRL 3 to TRL 4-‐6).


23

NEXT ACTIONS 1.  Conference proceedings book publica+on 2.  Brainstorming session of the coordinators of

the 6 projects –  to be scheduled

3.  Organisa+on of a brockerage event (June 2014) involving

–  researchers –  industries –  public bodies


24

THANKS to everybody for your par+cipa+on

to Paola Storici – coorganiser to Lucia Gardossi -‐ moderator


25

THANKS to Divulgando s.r.l

for crea+ve organisa+onal op+misa+on website annoncement and management, conference material,

pictures, logis+cs, post-‐event follow-‐up

h\p://www.units.it/vedinews/index.php?id=4209&+ponews=5 h\p://www.flickr.com/photos/trans2care/sets/72157641645322424/

Facts figures and features conference report / CONFERENCE: CROSS-BORDER ITALY-SLOVENIA BIOMEDICAL...

Education

Transcript of Facts figures and features conference report / CONFERENCE: CROSS-BORDER ITALY-SLOVENIA BIOMEDICAL...